Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...

A pharmacist has shared three things sufferers of a 'very common' condition should do to treat themselves after it was ...

The NHS has stopped prescribing certain 'over the counter' remedies for common ailments in a continued crackdown on ...

The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year and older with relapsed/refractory acute leukemia and a lysine methyltransferase 2A gene ( ...

NHS England has stopped prescribing certain 'over the counter' remedies for common ailments, with migraines, cold sores, ...

Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...

The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...

NHS England has ‘blacklisted’ 36 health conditions which cannot be treated with prescriptions and must instead be bought over ...

Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio"), a clinical stage, multi-asset immunology company developing novel dual-pathway ...

Prescriptions for a range of common 'over the counter' remedies are no longer available on the NHS after a crackdown in ...